Triple Negative Breast Neoplasms

SEP 10, 2026 · PHASE 3 TRIAL

Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss

ClinicalTrials.gov

This is a terminated Phase 3 trial registry record with no results posted; the study design and population are defined but no efficacy or safety data are available for assessment.

AUG 7, 2026 · PHASE 3 TRIAL

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

ClinicalTrials.gov

This is a Phase 3 trial registration with no results reported; it describes a planned study of sacituzumab tirumotecan in early breast cancer, currently recruiting.

AUG 7, 2026 · PHASE 3 TRIAL

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

ClinicalTrials.gov

This is a Phase 3 trial registration with no results yet posted; the study is actively recruiting and outcomes are not yet reported.